Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells

Nature Medicine

Volumn 10, Issue 12, 2004, Pages 1329-1335

  Polo, Jose M ^a   Dell'Oso, Tania ^a   Ranuncolo, Stella Maris ^a   Cerchietti, Leandro ^a   Beck, David ^a   Da Silva, Gustavo F ^a   Prive, Gilbert G ^b   Licht, Jonathan D ^c   Melnick, Ari ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B CELL LYMPHOMA 6 GENE; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; REPRESSOR GENE; TRANSCRIPTION REGULATION;

AMINO ACID MOTIFS; B-LYMPHOCYTES; BLOTTING, WESTERN; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REGULATOR; HUMANS; IMMUNOPRECIPITATION; LYMPHOMA, LARGE-CELL, DIFFUSE; MUTATION; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 11144277489     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1134     Document Type: Article

References (33)

1. Ye, B.H. The Role of BCL6 in Normal Lymphoid System and Non-Hodgkin's Lymphomas. in Transcription Factors: Normal and Malignant Development of Blood Cells, Vol. 1 (eds. Ravid, K. & Licht, J.D.) 271-289 (John Wiley & Sons, New York, 2001).
2. Shaffer, A.L. et al. BCL6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13, 199-212 (2000).
3. Niu, H. The proto-oncogene BCL6 in normal and malignant B cell development. Hematol. Oncol. 20, 155-166 (2002).
4. Albagli-Curiel, O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene 22, 507-516 (2003).
5. Prive, G.G., Melnick, A., Ahmad, K.F. & Licht, J.D. The BTB Domain Zinc Finger Proteins. in Zinc Finger Proteins: from Atomic Contact to Cellular Function (eds. Shiro, I. & Kuldell, N.) (Landes Biosciences, Georgetown, 2004).
6. Ahmad, K.F. et al. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12, 1551-1564 (2003).
7. Melnick, A. et al. Critical residues within the BTB domain of PLZF and BCL6 modulate interaction with corepressors. Mol. Cell. Biol. 22, 1804-1818 (2002).
8. Huynh, K.D., Fischle, W., Verdin, E. & Bardwell, V.J. BCoR, a novel corepressor involved in BCL6 repression. Genes Dev. 14, 1810-1823 (2000).
9. Chen, J.D. & Evans, R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457 (1995).
10. Horlein, A.J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404 (1995).
11. Yu, J., Li, Y., Ishizuka, T., Guenther, M.G. & Lazar, M.A. A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J. 22, 3403-3410 (2003).
12. Chevallier, N. et al. ETO protein of t(8;21) AML is a corepressor for BCL6 B-cell lymphoma oncoprotein. Blood 103, 1454-1463 (2004).
13. Schwarze, S.R., Hruska, K.A. & Dowdy, S.F. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295 (2000).
14. Huynh, K.D. & Bardwell, V.J. The BCL6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17, 2473-2484 (1998).
15. Deltour, S., Guerardel, C. & Leprince, D. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc. Natl. Acad. Sci. USA 96, 14831-14836 (1999).
16. Niu, H., Cattoretti, G. & Dalla-Favera, R. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J. Exp. Med. 198, 211-221 (2003).
17. Mehra, S., Messner, H., Minden, M. & Chaganti, R.S. Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chromosom. Cancer 33, 225-234 (2002).
18. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. & Staudt, L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL6. Science 276, 589-592 (1997).
19. Reljic, R., Wagner, S.D., Peakman, L.J. & Fearon, D.T. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL6. J. Exp. Med. 192, 1841-1848 (2000).
20. Gupta, S., Jiang, M., Anthony, A. & Pernis, A.B. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190, 1837-1848 (1999).
21. Harris, M.B. et al. Transcriptional repression of State-dependent interleukin-4-induced genes by BCL6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol. Cell. Biol. 19, 7264-7275 (1999).
22. Paterson, R.L. et al. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease. Eur. J. Immunol. 26, 1979-1984 (1996).
23. Allman, D. et al. BCL6 expression during B-cell activation. Blood 87, 5257-5268 (1996).
24. Ye, B.H. et al. The BCL6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16, 161-170 (1997).
25. Toney, L.M. et al. BCL6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1, 214-220 (2000).
26. Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572 (1999).
27. Wang, X., Li, Z., Naganuma, A. & Ye, B.H. Negative autoregulation of BCL6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc. Natl. Acad. Sci. USA 99, 15018-15023 (2002).
28. Vasanwala, F.H., Kusam, S., Toney, L.M. & Dent, A.L. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J. Immunol. 169, 1922-1929 (2002).
29. Fujita, N. et al. MTA3 and Mi-2/NuRD Complex Regulate Cell Fate During B-Lymphocyte Differentiation. Cell 119, 75-86 (2004).
30. Opalinska, J., Kalota, A. & Gerwitz, A. Design of Antisense Oligonucleotides, and Short Interfering RNA (siRNA) Duplexes, Targeted to BCL6 mRNA: Towards Rational Drug Development for Specific Lymphoma Subsets. Blood 102, 137a (2003).
31. Melnick, A. & Licht, J.D. Histone deacetylases as therapeutic targets in hematologic malignancies. Curr. Opin. Hematol. 9, 322-332 (2002).
32. Andrews, N.C. & Faller, D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499 (1991).
33. Lopes, E.C. et al. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Leuk. Res. 27, 413-423 (2003).